- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 333 South Hope Street, 55th Floor Los Angeles CA United States of America 90071
- IPO Date
- Feb 24, 2022
- Business
- Capital Group International Focus Equity ETF (CGXU) is an actively managed exchange-traded fund that primarily invests in common stocks of non-U.S. companies, including those domiciled in emerging markets, selected for their high growth potential by Capital Group portfolio managers. The ETF holds a diversified portfolio of approximately 80-83 equity securities, with top holdings including Novo Nordisk A/S Class B, Daiichi Sankyo Co Ltd, Reliance Industries Ltd, Recruit Holdings Co Ltd, and Nu Holdings Ltd; it emphasizes large-cap growth stocks across sectors such as healthcare, technology, energy, financial services, and consumer cyclical, with significant allocations to developed markets (around 71.5%) in regions like Britain, Japan, Canada, and Germany, as well as emerging markets (around 28%) including India, Taiwan, and South Korea. Launched on February 22, 2022, CGXU trades on the NYSE Arca exchange, manages assets under management of approximately $3.85 billion, and features an expense ratio of 0.54% with semi-annual distributions.
The fund operates globally, targeting investors seeking international equity exposure beyond the United States, and is issued by Capital Group Equity ETF Trust I under the sponsorship of Capital Group, a privately held investment management firm founded in 1931 and headquartered at 333 South Hope Street in Los Angeles, California. Recent institutional activity includes Cerity Partners LLC increasing its position in CGXU by 1.3% during the second quarter of 2025 through the acquisition of an additional 45,159 shares, bringing its total ownership to 3,578,528 shares. In November 2024, Capital Group Equity ETF Trust I filed an amended Form N-1A with the SEC, proposing updates potentially related to public offerings or prospectus revisions effective around December 2024, reflecting ongoing regulatory and operational enhancements. No major acquisitions, partnerships, new product launches, or strategic reorganizations specific to CGXU have been reported in the last 1-2 years.